
NeuroMetrix NURO
Quarterly report 2024-Q3
added 05-16-2026
NeuroMetrix Total Non Current Liabilities 2011-2026 | NURO
Annual Total Non Current Liabilities NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 917 K | - | - | 4.64 K | 280 K | 5.32 M | 1.95 M | 71.4 K | 119 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.32 M | 4.64 K | 1.24 M |
Total Non Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
1.54 B | $ 68.58 | -0.06 % | $ 13.7 B | ||
|
Glaukos Corporation
GKOS
|
87.4 M | $ 124.9 | -1.21 % | $ 7.14 B | ||
|
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | ||
|
Intuitive Surgical
ISRG
|
418 M | $ 425.07 | -0.36 % | $ 152 B | ||
|
Alcon
ALC
|
6.05 B | $ 67.23 | -0.99 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
66.7 M | $ 144.38 | 1.68 % | $ 3.56 B | ||
|
Repro Med Systems
KRMD
|
239 K | $ 4.03 | 0.75 % | $ 186 M | ||
|
iRhythm Technologies
IRTC
|
119 M | $ 116.7 | 2.52 % | $ 3.73 B | ||
|
LeMaitre Vascular
LMAT
|
19.3 M | $ 97.43 | 0.87 % | $ 2.21 B | ||
|
Masimo Corporation
MASI
|
56 M | $ 179.95 | - | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
760 K | $ 1.83 | 0.77 % | $ 83.8 M | ||
|
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
11.2 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
1.4 M | $ 0.39 | -0.31 % | $ 32 M | ||
|
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | ||
|
Merit Medical Systems
MMSI
|
626 M | $ 67.96 | 0.67 % | $ 4.02 B | ||
|
electroCore
ECOR
|
1.42 M | $ 9.52 | - | $ 80.8 K | ||
|
Envista Holdings Corporation
NVST
|
1.91 B | $ 24.48 | -0.45 % | $ 4.11 B | ||
|
Haemonetics Corporation
HAE
|
405 M | $ 79.66 | 1.17 % | $ 3.76 B | ||
|
STERIS plc
STE
|
1.53 B | $ 212.15 | -0.28 % | $ 20.8 B | ||
|
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
12.5 M | $ 29.97 | 0.33 % | $ 1.49 B | ||
|
InfuSystem Holdings
INFU
|
35 M | $ 9.03 | 0.22 % | $ 187 M | ||
|
Teleflex Incorporated
TFX
|
2.77 B | $ 134.56 | -0.88 % | $ 6 B | ||
|
Utah Medical Products
UTMD
|
5.25 M | $ 68.07 | - | $ 221 M | ||
|
West Pharmaceutical Services
WST
|
427 M | $ 332.82 | -0.63 % | $ 24.1 B | ||
|
Pulse Biosciences
PLSE
|
6.72 M | $ 25.25 | -2.04 % | $ 1.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 10.45 | -0.19 % | $ 2.08 B | ||
|
Retractable Technologies
RVP
|
2.38 M | $ 0.69 | -0.03 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
9.93 M | $ 65.09 | 0.14 % | $ 214 M | ||
|
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
41.7 M | $ 28.02 | 1.71 % | $ 1.34 B | ||
|
Stereotaxis
STXS
|
1.65 M | $ 1.83 | -1.08 % | $ 166 M | ||
|
Baxter International
BAX
|
7.05 B | $ 20.34 | 1.55 % | $ 10.4 B | ||
|
ResMed
RMD
|
1.05 B | $ 196.36 | -0.32 % | $ 28.7 B | ||
|
AtriCure
ATRC
|
261 M | $ 27.78 | 1.74 % | $ 1.33 B | ||
|
Harvard Bioscience
HBIO
|
58.5 M | $ 6.15 | 1.82 % | $ 273 M | ||
|
AngioDynamics
ANGO
|
148 M | $ 12.46 | 0.97 % | $ 509 M | ||
|
Becton, Dickinson and Company
BDX
|
25 B | $ 151.46 | -0.39 % | $ 43.6 B | ||
|
Nephros
NEPH
|
1.61 M | $ 3.19 | -1.82 % | $ 33.9 M | ||
|
OraSure Technologies
OSUR
|
22.5 M | $ 4.27 | 0.71 % | $ 314 M | ||
|
Repligen Corporation
RGEN
|
708 M | $ 133.39 | 2.51 % | $ 7.5 M |